What does CUSIP 29668H104 represent in this 13F holders report?

CUSIP 29668H104 is the security identifier for 29668H104 - ESSA PHARMA INC - COM used to aggregate holder disclosures.

How many institutions held 29668H104 - ESSA PHARMA INC - COM in Q4 2017?

8 institutional investors reported 29668H104 - ESSA PHARMA INC - COM for Q4 2017. Use the holders table for investor-level position and value details.

ESSA PHARMA INC - COM

CUSIP: 29668H104

Q4 2017 13F Holders as of 31 Dec 2017

Type / Class: Equity / COM
Total 13F shares: 6,899,690
Share change: +46,229
Total reported value: $1,492,000
Price per share: $0.22
Number of holders: 8
Value change: +$7,885
Number of buys: 3
Number of sells: 3

Quarterly Holders Quick Answers

What is CUSIP 29668H104?
CUSIP 29668H104 identifies 29668H104 - ESSA PHARMA INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2018
Previous quarter: Q3 2017

Recent filing periods for CUSIP 29668H104:

Q3 2018 Q2 2018 Q1 2018 Q4 2017 Q3 2017 Q2 2017 Q1 2017 Q4 2016

Institutional Holders of ESSA PHARMA INC - COM as of Q4 2017

As of 31 Dec 2017, ESSA PHARMA INC - COM was held by 8 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 6,899,690 shares. The largest 8 holders included EVENTIDE ASSET MANAGEMENT, LLC, Clarus Ventures, LLC, Omega Fund Management, LLC, CIBC World Markets Inc., SUSQUEHANNA INTERNATIONAL GROUP, LLP, ROYAL BANK OF CANADA, CITADEL ADVISORS LLC, and UBS Group AG. This page lists 8 institutional shareholders reporting positions in this security for the Q4 2017 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.